Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis

European Journal of Clinical Pharmacology
A MessoriG Zaccara

Abstract

Lamotrigine as add-on treatment (500 mg per day) is effective in patients with refractory epilepsy, but its high cost requires a pharmacoeconomic analysis. We conducted a retrospective lifetime cost utility study in which clinical data were derived from a recent placebo-controlled clinical trial, cost-of-illness data were drawn from a previous ad-hoc study, and quality-of-life values were obtained by prospectively interviewing a separate group of 81 patients referred to our institution with epilepsy. Our analysis showed that chronic lamotrigine treatment implies an incremental lifetime cost of about $1,600,000 for every 100 patients. Incremental lifetime utility was around 40 quality-adjusted life-years (QALYs) for every 100 patients. On the basis of these data, adjunctive lamotrigine was estimated to cost approximately $41,000 per QALY gained. Sensitivity testing suggested a range of $25,000-$85,000 per QALY gained. Adjunctive lamotrigine (500 mg per day) in refractory epilepsy seems to have a worse pharmacoeconomic profile than many pharmacological treatments commonly used in areas other than epilepsy. Further data are needed to determine if lamotrigine can be equally effective at lower (and less costly) daily doses which cou...Continue Reading

Citations

Jun 18, 2003·Seizure : the Journal of the British Epilepsy Association·Raeburn B ForbesRichard C Roberts
Sep 12, 2003·Seizure : the Journal of the British Epilepsy Association·Rajiv Mohanraj, Martin J Brodie
Jun 13, 2002·Epilepsia·Dominic C Heaney, Charles E Begley
Jul 8, 2000·Epilepsia·J T Langfitt
Feb 27, 2007·Epilepsia·Charles E BegleyUNKNOWN ILAE Commission on Healthcare Policy
May 8, 2002·CNS Drugs·Meir BialerJosemir W Sander
Jul 24, 2004·CNS Drugs·Barbara C Jobst, Gregory L Holmes
Dec 4, 2014·Seizure : the Journal of the British Epilepsy Association·Samah K AburahmaAmira Masri
Jan 21, 2012·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Sandra L HelmersEdward Faught
Feb 2, 2013·Acta Neurologica Scandinavica·B KristianL Forsgren
Mar 5, 2010·Acta Neurologica Scandinavica·K BolinL Forsgren
Nov 18, 2005·Epilepsy Research·P D KnoesterC L P Deckers
Oct 9, 2012·Epilepsy & Behavior : E&B·Nathalie JetteSamuel Wiebe
Dec 13, 2006·Seizure : the Journal of the British Epilepsy Association·Emma J FrewStirling Bryan
Sep 15, 2005·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Neil HawkinsMark Sculpher
Jun 19, 2018·Expert Review of Pharmacoeconomics & Outcomes Research·Melissa H RobertsMatthew E Borrego
Jun 1, 2005·Expert Review of Pharmacoeconomics & Outcomes Research·Demetris Pillas, Caroline Selai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.